.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
India recently launched a groundbreaking global clinical study evaluating Ayurveda in TB treatment as a supportive therapy. This initiative aims to scientifically validate traditional medicine alongside modern regimens. Consequently, researchers will monitor how these combined therapies influence patient recovery and long-term health outcomes. Furthermore, the collaboration between the Ministry of Ayush and the Department of Biotechnology marks a significant milestone in integrative healthcare.
The study involves 1,250 newly diagnosed tuberculosis patients across eight major institutions. Participants will receive standard anti-tuberculosis treatment alongside a defined Ayurveda regimen. Additionally, investigators will track changes in body weight and nutritional status. They will also assess disease progression and the overall quality of life for participants. Safety and tolerability remain primary endpoints throughout this trial.
Many patients experience persistent weakness even after completing successful antibiotic courses. Therefore, Union Minister Jitendra Singh emphasized the need for host-directed therapies. India's rich heritage of Ayurveda offers unique opportunities to boost immunity and enhance nutrition. This holistic approach might bridge the gap in current care protocols. Moreover, it aligns with India's goal of eliminating TB by 2025.
India currently accounts for nearly 25 percent of the global TB burden. However, the nation saw a 21 percent reduction in incidence between 2015 and 2024. This drop reflects the success of early diagnosis and universal drug testing. Thus, the government continues to strengthen patient-centric care under the National TB Elimination Programme. This clinical trial supports these ongoing efforts effectively.
Q1: What is the primary goal of this clinical study?
The study aims to evaluate Ayurveda as an adjunct therapy to improve nutritional outcomes, immunity, and quality of life in TB patients.
Q2: How many patients are participating in the trial?
The trial will enrol 1,250 newly diagnosed TB patients across eight different institutions in India.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
India starts a clinical study on 1,250 patients to evaluate Ayurveda as an adjunct to TB treatment for better recovery, nutrition, and overall quality of li...
5 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
